Published in Eur J Pediatr on August 26, 2009
Dyssynchronous ventricular activation in asymptomatic wolff-Parkinson-white syndrome: a risk factor for development of dilated cardiomyopathy. Indian Pacing Electrophysiol J (2010) 1.07
Evaluation by N-terminal prohormone of brain natriuretic peptide concentrations and ross scoring of the efficacy of digoxin in the treatment of heart failure secondary to congenital heart disease with left-to-right shunts. Pediatr Cardiol (2013) 0.76
Pediatric cardiac emergencies: Children are not small adults. J Emerg Trauma Shock (2011) 0.75
The incidence of congenital heart disease. J Am Coll Cardiol (2002) 16.13
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation (1996) 9.00
Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA (2006) 4.51
Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol (2006) 3.85
Nesiritide - not verified. N Engl J Med (2005) 3.41
The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med (2003) 3.28
Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA (2002) 3.24
Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation (2004) 3.05
Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study. Eur J Cancer (2006) 2.99
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol (2005) 2.71
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation (2003) 2.67
Death in infancy from unrecognised congenital heart disease. Arch Dis Child (1994) 2.60
Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation (2003) 2.33
Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol (1998) 2.27
Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation (2005) 2.15
Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment. Ann Emerg Med (2008) 2.12
Spontaneous regression of left ventricular dilation in children with restrictive ventricular septal defects. J Pediatr (2007) 2.05
Early experience with Levosimendan in children with ventricular dysfunction. Pediatr Crit Care Med (2006) 2.01
Worsening renal function in children hospitalized with decompensated heart failure: evidence for a pediatric cardiorenal syndrome? Pediatr Crit Care Med (2008) 1.94
Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol (2002) 1.93
Chronic kidney disease in patients with chronic heart failure--impact on intracardiac conduction, diastolic function and prognosis. Int J Cardiol (2006) 1.80
Congestive heart failure. Pediatrics (1956) 1.69
Pediatric myocarditis: emergency department clinical findings and diagnostic evaluation. Pediatrics (2007) 1.68
Cardiac and clinical phenotype in Barth syndrome. Pediatrics (2006) 1.61
Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics (2006) 1.59
Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects. Circulation (1993) 1.45
Nesiritide in infants and children with congestive heart failure. Pediatr Crit Care Med (2005) 1.43
Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. J Am Coll Cardiol (2003) 1.41
Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation (2000) 1.36
Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. Am J Epidemiol (1997) 1.29
Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy. J Med Virol (2008) 1.18
The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis. Eur J Heart Fail (2002) 1.17
X linked fatal infantile cardiomyopathy maps to Xq28 and is possibly allelic to Barth syndrome. J Med Genet (1995) 1.16
Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. Am J Cardiol (2005) 1.13
Cardiomyopathy in muscular dystrophies. Curr Opin Neurol (2003) 1.12
Myocardial tissue characterization and the role of chronic anemia in sickle cell cardiomyopathy. J Magn Reson Imaging (2007) 1.10
Outcome of acute fulminant myocarditis in children. Heart (2006) 1.10
A case of anomalous left coronary artery. Br Heart J (1951) 1.05
Cardiac findings in adolescents with anorexia nervosa at diagnosis and after weight restoration. Eur J Pediatr (2005) 1.02
Echocardiographic predictors of adverse clinical events in children with dilated cardiomyopathy: a prospective clinical study. Heart (2004) 1.00
Epidemiology of heart failure in a tertiary pediatric center. Clin Cardiol (2008) 0.98
Cardiac disease in Costello syndrome. Pediatrics (1998) 0.98
Ventricular septal defect. I. Congestive heart failure in infancy. Pediatrics (1960) 0.97
Review: Metabolic cardiomyopathy and conduction system defects in children. Ann Clin Lab Sci (2004) 0.92
Effects of exogenous and endogenous natriuretic peptides on forearm vascular function in chronic heart failure. Arterioscler Thromb Vasc Biol (2004) 0.91
Beyond diuretics: management of volume overload in acute heart failure syndromes. Am J Med (2006) 0.89
Risk of death associated with nesiritide in patients with acutely decompensated heart failure. JAMA (2006) 0.89
Idiopathic dilated cardiomyopathy as a late complication of healed viral (Coxsackie B virus) myocarditis: historical analysis, review of the literature, and a postulated unifying hypothesis. Prog Cardiovasc Dis (2006) 0.88
Congenital heart disease in live-born children: incidence, distribution, and yearly changes in the Campania Region. J Cardiovasc Med (Hagerstown) (2008) 0.88
Dilated cardiomyopathy in dystrophic epidermolysis bullosa. Arch Dis Child (2000) 0.87
Levosimendan for low cardiac output: a pediatric experience. J Intensive Care Med (2006) 0.87
Impaired muscle metaboreflex-induced increases in ventricular function in heart failure. Am J Physiol Heart Circ Physiol (2004) 0.86
Point prevalence of cardiac abnormalities in children with systemic lupus erythematosus. J Rheumatol (2001) 0.85
Noninvasive ventilation outcomes in 2,430 acute decompensated heart failure patients: an ADHERE Registry Analysis. Acad Emerg Med (2008) 0.84
The utility of levosimendan in the treatment of heart failure. Ann Med (2007) 0.82
Pharmacokinetics of levosimendan in pediatric patients evaluated for cardiac surgery. Pediatr Crit Care Med (2004) 0.81
Cardiac abnormalities in children with systemic lupus erythematosus. Turk J Pediatr (2004) 0.80
Preload-dependent hemodynamic effects of milrinone in moderate heart failure. Cardiology (1992) 0.79
Normalization of the blunted ventilatory response to acute hypoxia in congenital cyanotic heart disease. N Engl J Med (1977) 0.78
Thyrotoxicosis-an uncommon cause of heart failure. Cardiovasc Pathol (2005) 0.77
Overview of current noninodilator therapies for acute heart failure syndromes. Am J Cardiol (2005) 0.76
Immune suppressive treatment in paediatric myocarditis: still awaiting the evidence. Heart (2004) 0.75
Acute effects of intravenous milrinone in heart failure. Eur Heart J (1989) 0.75
Perioperative effects and safety of nesiritide following cardiac surgery in children. J Intensive Care Med (2006) 0.75
Treatment of congestive heart failure. JAMA (2002) 0.75
Longevity and durability of atrioventricular valve repair in single-ventricle patients. Ann Thorac Surg (2012) 1.41
Primary sutureless repair for "simple" total anomalous pulmonary venous connection: midterm results in a single institution. J Thorac Cardiovasc Surg (2011) 1.04
Imaging the right heart: the use of integrated multimodality imaging. Eur Heart J (2012) 0.99
Developments in echocardiographic techniques for the evaluation of ventricular function in children. Arch Cardiovasc Dis (2010) 0.90
Clinical practice: heart failure in children. Part II: current maintenance therapy and new therapeutic approaches. Eur J Pediatr (2010) 0.79
Are children with genetic disorders at increased risk of postoperative complications after cardiac surgery? Pediatr Crit Care Med (2011) 0.75
Recent evolutions in pediatric and congenital echocardiography. Curr Opin Cardiol (2015) 0.75
Impact of childhood obesity on cardiac structure and function. Curr Treat Options Cardiovasc Med (2014) 0.75
Late functional outcomes after repair of tetralogy of Fallot with atrioventricular septal defect: a double case-match control study. J Thorac Cardiovasc Surg (2013) 0.75
Right ventricular remodelling after tetralogy of Fallot repair: new insights from longitudinal follow-up data. Eur Heart J Cardiovasc Imaging (2017) 0.75